ISTOCK, BERNARDASV
Update (November 26): Verily has paused development of its glucose-sensing contact lens. The company, formerly Google Life Sciences, acknowledged in a statement earlier this month (November 16) that “there was insufficient consistency in our measurements of the correlation between tear glucose and blood glucose concentrations to support the requirements of a medical device.”
In the early 2000s, a long-standing problem affecting diabetes sufferers around the world seemed on the brink of being solved. After years of research and development, a needle-free device to measure a person’s blood glucose levels was coming to market—a game-changer for patients fed up with the messy and painful procedure of the blood-drawing finger-prick test.
Worn like a wristwatch, Cygnus Incorporated’s GlucoWatch G2 Biographer used weak electric currents to draw glucose ...
